MEANS FOR TREATING AUTO-IMMUNE DISEASES AND METHOD OF TREATMENT

Trophoblastic beta-1 glycoprotein in in amount 3 to 120 ug/ml may be used for preparation of parenteral or endovenous preparation for treatment of autoimmune diseases. This preparations modificates immunity without additional effects. It may be used for diagnosis of supressor component of the state...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KACHARAVA LEONID Y, ALIKHANOV KHALLAR A, TATARINOV JURY S, GOLOVISTIKOV IVAN N
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Trophoblastic beta-1 glycoprotein in in amount 3 to 120 ug/ml may be used for preparation of parenteral or endovenous preparation for treatment of autoimmune diseases. This preparations modificates immunity without additional effects. It may be used for diagnosis of supressor component of the state of human immunity and to consideration of the possibility of treatment of disseminated sclerosis, rheumatic artritidis and similar autoimmune diseases.